2m 2m 2m 2m 2m 2m 2m
VivoSim (VIVS)
NASDAQ
$1.12-$0.009 (-0.80%)
Price as of Jun 23, 2026 7:10 PM EDT- $3.3MMarket Cap
- -26.38%1-Year Change
- BiotechnologyIndustry
VivoSim (VIVS)
$1.12-$0.009 (-0.80%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 119,000 +9.17% | 109,000 -70.54% | 370,000 -75.33% | 1.5M N/A | |
Cost of Revenue | 5,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 114,000 +4.59% | 109,000 -70.54% | 370,000 -75.33% | 1.5M N/A | |
Sales and Marketing Expense | 7.7M -20.28% | 9.7M +5.22% | 9.2M -4.59% | 9.7M -38.57% | |
Research and Development Expense | -5.0M -8.60% | -5.5M -38.12% | -8.9M +167.62% | -3.3M +201.00% | |
Depreciation and Amortization Expense | 266,000 -5.00% | 280,000 -4.44% | 293,000 +106.34% | 142,000 +246.34% | |
Total Operating Expenses | 12.8M -16.03% | 15.2M -16.05% | 18.1M +39.46% | 13.0M -22.86% | |
Operating Profit | -12.6M -16.37% | -15.1M -14.92% | -17.7M +54.46% | -11.5M -31.78% | |
Interest Income | 140,000 -65.43% | 405,000 -10.79% | 454,000 +5,575.00% | 8,000 -46.67% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 140,000 -65.43% | 405,000 -10.79% | 454,000 +5,575.00% | 8,000 -46.67% | |
Total Nonoperating Income and Expense | 10.1M +2,329.26% | 417,000 -12.03% | 474,000 +1,336.36% | 33,000 +1,550.00% | |
Income before Taxes | -12.6M -16.37% | -15.1M -14.92% | -17.7M +54.46% | -11.5M -31.78% | |
Income Taxes | 2,000 0.00% | 2,000 0.00% | 2,000 0.00% | 2,000 0.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -2.5M -83.04% | -14.7M -15.00% | -17.3M +50.76% | -11.4M -31.96% | |
Net Income from Continuing Operations Applicable to Common | -2.5M -83.04% | -14.7M -15.00% | -17.3M +50.76% | -11.4M -31.96% | |
Basic EPS and Net Income | -1.70 +6.25% | -1.60 -19.19% | -1.98 +50.00% | -1.32 -45.90% | |
Diluted EPS and Net Income | -1.70 +6.25% | -1.60 -19.19% | -1.98 +50.00% | -1.32 -45.90% | |
Basic Weighted Average Shares | 1.5M -84.00% | 9.1M +4.96% | 8.7M +0.11% | 8.7M +26.10% | |
Diluted Weighted Average Shares | 1.5M -84.00% | 9.1M +4.96% | 8.7M +0.11% | 8.7M +26.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 11.3M +289.93% | 2.9M -81.04% | 15.3M -46.64% | 28.7M -23.26% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 11.3M +289.93% | 2.9M -81.04% | 15.3M -46.64% | 28.7M -23.26% | |
Total Current Assets | 12.1M +208.21% | 3.9M -76.91% | 17.0M -42.27% | 29.5M -23.09% | |
Accumulated Depreciation | 1.5M +20.91% | 1.3M -1.41% | 1.3M +19.14% | 1.1M +6.89% | |
Property and Plant and Equipment and Net | 419,000 -37.37% | 669,000 -25.83% | 902,000 +36.25% | 662,000 +73.75% | |
Total Long-Term Assets | 419,000 -37.37% | 669,000 -25.83% | 902,000 +36.25% | 662,000 -35.54% | |
Total Assets | 14.7M +130.74% | 6.3M -68.74% | 20.3M -38.99% | 33.3M -16.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.7M +100.91% | 1.9M -49.33% | 3.7M +165.44% | 1.4M +91.82% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 421,000 -52.59% | 888,000 -32.37% | 1.3M -22.95% | 1.7M N/A | |
Total Liabilities | 4.2M +51.31% | 2.7M -44.86% | 5.0M +61.45% | 3.1M +328.16% | |
Retained Earnings | -342.2M +0.73% | -339.7M +4.51% | -325.0M +5.61% | -307.7M +3.86% | |
Total Stockholders Equity | 10.5M +191.36% | 3.6M -76.51% | 15.3M -49.26% | 30.2M -22.93% | |
Total Shares Outstanding | 1.9M -81.17% | 10.1M +15.61% | 8.7M +0.07% | 8.7M +0.46% | |
Cash Flow | |||||
Cash from Operating Activities | -9.5M -35.43% | -14.7M +18.09% | -12.4M +46.79% | -8.5M -36.55% | |
Capital Expenditures | 13,000 -69.05% | 42,000 -89.39% | 396,000 -3.18% | 409,000 +0.99% | |
Cash from Investing Activities | 9.0M +1,006.00% | 816,000 +184.47% | -966,000 +136.19% | -409,000 +4.07% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.8M +515.66% | 1.4M N/A | 0 -100.00% | 205,000 -99.14% | |
Financials Ratio | |||||
Gross Margin | 95.80% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -10,601.68% -23.40% | -13,840.37% +188.81% | -4,792.16% +526.21% | -765.27% N/A | |
Return on Assets | -23.70% -78.47% | -110.05% +70.92% | -64.39% +105.89% | -31.27% -36.47% | |
Return on Equity | -35.31% -77.22% | -155.00% +104.49% | -75.80% +129.77% | -32.99% -35.47% | |
Revenue Growth | 9.17% +113.01% | -70.54% -6.36% | -75.33% N/A | N/A N/A | |
Current Ratio | 3.25 +53.40% | 2.12 -54.43% | 4.64 -78.25% | 21.35 -59.90% | |
Cash Ratio | 3.03 +94.08% | 1.56 -62.58% | 4.17 -79.90% | 20.73 -59.99% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow